ACT Biotech is a privately-held biopharmaceutical company focused on the development and commercialization of targeted, orally available cancer drugs.

The Company’s three programs each target a different family of receptor tyrosine kinases. These programs target well validated anti-cancer receptors and have been rationally designed to overcome the drawbacks of first generation molecules. One of the programs targets a unique set of receptors to provide a combination of anti-cancer modalities not available in any other anti-cancer agent.

The company was founded in 2008 and the products upon which the company was founded are highly validated in multiple pre-clinical and clinical studies. They were originally developed at Bayer Pharmaceuticals and were licensed by ACT Biotech in 2008 following Bayer’s merger with Schering AG.

ACT Biotech's venture investor is NGN Capital of New York, Connecticut and Heidelberg, Germany. The company is located in San Francisco, California.

Windows 7 Home premium Product Key Windows 7 Pro Activation Key Windows 7 Home premium Product Key Windows 7 Pro Activation Key Windows 7 Professional Activation Key Windows 7 Home premium Activation Key Windows 7 Professional Activation Key Windows 7 Home premium Activation Key Windows vista Home premium Product Key Product Key Windows 7 Professional 32 bit Windows vista Home premium Product Key Product Key Windows 7 Professional 32 bit Upgrade Key for Windows 7 Professional Upgrade Key for Windows 7 Professional

www.actbiotech.comwww.actbiotech.comwww.actbiotech.com